BlackRock Health Sciences Term Trust $BMEZ Stock: Oppenheimer & Co. Inc. Raises Stake

Oppenheimer & Co. Inc. boosted its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 96.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 197,033 shares of the company’s stock after purchasing an additional 96,920 shares during the period. Oppenheimer & Co. Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $3,290,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Kingswood Wealth Advisors LLC grew its position in BlackRock Health Sciences Term Trust by 16.8% in the 3rd quarter. Kingswood Wealth Advisors LLC now owns 12,278 shares of the company’s stock worth $205,000 after purchasing an additional 1,762 shares during the period. Integrated Wealth Concepts LLC bought a new position in shares of BlackRock Health Sciences Term Trust during the 2nd quarter valued at $46,000. Brown Lisle Cummings Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 7.8% during the 2nd quarter. Brown Lisle Cummings Inc. now owns 57,026 shares of the company’s stock valued at $875,000 after buying an additional 4,108 shares during the period. Corient Private Wealth LP bought a new position in shares of BlackRock Health Sciences Term Trust during the 2nd quarter valued at $467,000. Finally, Rivernorth Capital Management LLC boosted its stake in shares of BlackRock Health Sciences Term Trust by 24.8% in the 1st quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock worth $11,620,000 after buying an additional 160,629 shares during the last quarter.

BlackRock Health Sciences Term Trust Stock Performance

BMEZ stock opened at $17.54 on Friday. BlackRock Health Sciences Term Trust has a 1 year low of $13.70 and a 1 year high of $17.96. The stock’s fifty day moving average price is $16.74 and its 200-day moving average price is $15.32.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Tuesday, December 22nd. Shareholders of record on Friday, December 11th will be issued a $0.11 dividend. The ex-dividend date of this dividend is Friday, December 11th. This represents a $1.32 dividend on an annualized basis and a yield of 7.5%.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a closed-end investment fund managed by BlackRock Advisors. The fund seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity securities of companies involved in the health sciences sector.

Its investment universe may include biotechnology, pharmaceuticals, medical devices, health-care services, life sciences tools and related businesses. The portfolio can hold investments in companies across different stages of development and in multiple countries, giving shareholders exposure to global health-care innovation and research.

BlackRock Health Sciences Term Trust is structured as a term trust, meaning it was established with a planned termination date, subject to applicable shareholder and board actions.